SCHEMBL28923912

SCHEMBL28923912

CCOC(=O)C(=C=O)Cc1ccc(F)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CA P42336 1/20 0.44
TSHR P16473 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
MME P08473 1/20 0.38
ACE P12821 1/20 0.38
KCNJ6 P48051 1/20 0.38
KCNJ5 P48544 1/20 0.38
KCNJ3 P48549 1/20 0.38
CYP4F2 P78329 1/20 0.37
CYP4A11 Q02928 1/20 0.37
RPA1 P27694 1/20 0.37
CA2 P00918 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPT P10636 1/20 0.37
ALOX15 P16050 1/20 0.37
P2RX7 Q99572 1/20 0.37
ABCB1 P08183 1/20 0.36
CNR2 P34972 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28923911 0.83 PIK3CA (0.48) PIK3CATSHRSMN1; SMN2KCNJ6KCNJ5
SCHEMBL28638605 0.83 PIK3CA (0.50) PIK3CATSHRKCNJ6KCNJ5KCNJ3
SCHEMBL28547028 0.75 MEN1 (0.49) TSHRSMN1; SMN2ALDH1A1MAPTL3MBTL1
SCHEMBL20681282 0.75 TSHR (0.57) TSHRSMN1; SMN2MMEACEALDH1A1
SCHEMBL30965434 0.75 TSHR (0.57) TSHRSMN1; SMN2MMEACEALDH1A1
SCHEMBL1699591 0.74 PIK3CA (0.44) PIK3CATSHRSMN1; SMN2KCNJ6KCNJ5
SCHEMBL1699588 0.74 PIK3CA (0.44) PIK3CATSHRSMN1; SMN2KCNJ6KCNJ5
SCHEMBL869116 0.73 CA2 (0.65) PIK3CATSHRRPA1CA2ALDH1A1
SCHEMBL15262338 0.73 CYP2C9 (0.40) PIK3CATSHRSMN1; SMN2MMEACE
SCHEMBL901787 0.72 CYP4F2 (0.56) PIK3CATSHRSMN1; SMN2CYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109761986-B Tricyclic derivative inhibitor, preparation method and application thereof 上海翰森生物医药科技有限公司 2021-10-08 CN disclosed